The GAs interact with receptor tyrosine kinase (RTK) and modulate cancer pathways through the IR, IGFR-1, IGFR-2, VEGFR-1, VEFGR-2, and EGFR signaling networks. The gene discussed is FLT1; the disease is cancer.